Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.
about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationMolecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in MiceGalectins: regulators of acute and chronic inflammationMesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic micePluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-β1.Suppression of autoimmune diabetes by soluble galectin-1Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.Antigen-specific therapeutic approaches in Type 1 diabetesFunctions of cell surface galectin-glycoprotein lattices.When galectins recognize glycans: from biochemistry to physiology and back againTissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD miceTolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells.Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.Roles of galectins in inflammatory bowel disease.Mammalian glycosylation in immunity.Galectins in the Pathogenesis of Rheumatoid Arthritis.Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments.The immunotherapeutic potential of dendritic cells in type 1 diabetes.Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.Galectin-1 and immunotherapy for brain cancer.Dendritic cell therapy for Type 1 diabetes suppression.Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation.Galectin-1-Driven Tolerogenic Programs Aggravate Yersinia enterocolitica Infection by Repressing Antibacterial Immunity.Reg3g overexpression promotes β cell regeneration and induces immune tolerance in nonobese-diabetic mouse model.Galectin-1-asialofetuin interaction is inhibited by peptides containing the tyr-xxx-tyr motif acting on the glycoprotein.Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
P2860
Q21284774-148D7957-E10E-4C06-81BA-4C0A107906B4Q26765030-7A786EE5-1912-44F7-9F1F-4A69E32328E6Q28272886-8D09C5B5-4C21-4080-8E2F-3AFB42D5BDB6Q33302407-68B44420-52FC-4881-8A93-661C6440F809Q33649618-D49B423D-58F7-4279-A63E-F70EF9C86AC6Q33722118-5B385E41-F980-4222-B811-7EF9E52E4C1AQ34087128-3A25C0EB-266C-4236-934C-16140934B309Q34660346-C99D3C0C-C9B8-4867-80B7-DB4415028237Q35762883-98758E8A-394D-4FB2-8DF8-5CF9C0511ED3Q36178638-8EDCFD4B-C894-4D91-9FA6-7DB8975749B4Q36196146-F4390DB5-4E15-4A7A-8DBC-AB48D41D9DE5Q36755359-6EADD2F4-75CC-4AFD-B4F0-74D7F4F6E690Q36903097-3B287CF8-ED10-497D-BAEF-A28D8FB6AD58Q37026218-5B1FCD2D-B41A-4919-9B81-672DBACE9ED1Q37032635-BD339749-133D-480C-B0A9-15A228B590E3Q37262997-FBBE3824-1A6A-4890-8DE1-A5CAFEB803CDQ37290930-B9C9FF42-8573-46C6-B6C0-EAFDD1DACA3CQ37457505-085798EC-F60A-4856-B6E2-256E62A953B5Q37548648-CDBEE5EA-FF83-4526-B1AD-655CCDD20568Q37759033-17DA16E8-44DF-4DB4-A708-551FD1129969Q37793233-A97A657E-C4B4-46AF-B3D6-A4EB9D826B32Q37862237-53F89443-C811-4049-8506-235CC6018C71Q38059518-46F30963-6BC2-4F98-AF65-243B99538F34Q38071420-9CE5AB71-6BA3-4CCE-80E6-76846FDD770EQ38833613-8CD2850A-B240-49A3-A7F0-F57F09606A93Q40131199-22B377C5-C8B6-4BBD-B6BC-4B73BB59ACB9Q41050742-C207A6A0-74A6-405A-A6EB-88D8B5F239E5Q43235844-A00B4A43-9390-4AEE-A8B5-0FDAAC843C7CQ44298534-728FA3AB-41F7-4D59-BDC3-CB8AF40B528EQ47121682-A0B6F9B2-F153-46D3-AAE9-F80A5DC2FBD4Q48316500-A760302E-D307-4CDA-9319-E0C2A97D4738Q54327668-8B985862-F880-47D5-BEBF-1C26500D3352Q58831417-404BE234-6E73-41AD-B997-9F24D4437372
P2860
Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@en
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@nl
type
label
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@en
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@nl
prefLabel
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@en
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@nl
P2093
P1476
Dendritic cells expressing tra ...... f autoimmune diabetes in mice.
@en
P2093
Adrian E Morelli
Jon D Piganelli
Linda G Baum
Marcelo J Perone
Massimo Trucco
William J Shufesky
Zakaria S Tawadrous
P304
P356
10.4049/JIMMUNOL.177.8.5278
P407
P577
2006-10-01T00:00:00Z